Wed, Apr 26, 2017
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

MSCI Indices 2011 performance results

Tuesday, January 03, 2012
  • Global markets posted significant negative returns primarily due to European debt crisis worries and global economic growth uncertainties
  • Emerging and Frontier Markets showed the weakest performance
  • In a difficult market environment, the MSCI ACWI Minimum Volatility Index—a minimum variance strategy index—yielded a positive return of 2.42%

Opalesque Industry Update - MSCI Inc., a leading provider of investment decision support tools worldwide, including indices, portfolio risk and performance analytics and corporate governance services, today published the 2011 performance of its MSCI Indices, revealing a significant slowdown in global equity markets.

Major financial markets worldwide closed well below 2010 year-end levels across all size segments. MSCI ACWI IMI, comprised of close to 9,000 large, mid and small cap securities across 24 Developed and 21 Emerging Markets countries, for example, delivered a 2011 year-to-date performance of -10.23% versus 12.14% in 2010.

MSCI Developed Markets Indices demonstrated the best relative performance in 2011, with the MSCI World Index posting a year-to-date 2011 return of -8.01%. Within the Developed Markets countries and regions, however, a wide range of negative returns prevailed. The MSCI Europe Index significantly underperformed the MSCI USA Index, for example, with a year-to-date return of -14.98% versus a return of 0.30% for the MSCI USA Index. Europe’s poor 2011 performance record can be explained by the sovereign debt crisis that has evolved into an expanded Euro crisis. All major continental European markets have been impacted from Greece and Italy to France and Germany, which all posted negative year-to-date MSCI index returns of -64.48%, -27.05%, -20.53% and -21.12% respectively.

The MSCI Ireland Index was the one Developed Markets index to post a positive return of 7.76%.

Emerging Markets countries and regions were also substantially impacted by the 2011 slowdown: the MSCI Emerging Markets Index showed a 2011 year-to-date performance of -20.6% versus a return of 16.4% return in 2010. The MSCI Indonesia Index was the single country index posting a positive year-to-date return of 3.74%. The MSCI Turkey, India and Egypt Indices were the worst performers year-to-date with returns of -36.69%, -37.58%, and -48.78%, respectively.

The MSCI Frontier Markets Index performed in line with the MSCI Emerging Markets Index in 2011, returning -22.05% compared to a 19.0% return in 2010. The strongest regional performance within Frontier Markets came from the Europe, Middle East and Africa (EMEA) region. The MSCI Frontier Markets Africa Index showed a year-to-date return of -19.47%, with the MSCI Qatar Index posting a positive 4.35% return.

In terms of MSCI index size segments, the MSCI Global Small Cap Indices underperformed the MSCI Global Standard (Large + Mid Cap) Indices across all regions, whereas small caps outperformed large and mid cap equities in both 2010 and 2009. The MSCI ACWI Small Cap Index underperformed its large and mid cap counterpart, MSCI ACWI, by more than three percentage points year-to-date, returning -13.09% year-to-date versus MSCI ACWI’s return of -9.78% year-to-date.

The MSCI Minimum Volatility Indices notably outperformed traditional market capitalization MSCI Indices in 2011. The MSCI ACWI Minimum Volatility Index posted strong performance in both relative and absolute terms versus MSCI ACWI, for example, with a year-to-date return of 2.42%. The MSCI World Minimum Volatility Index also returned 4.27% year-to-date in 2011, in contrast to the MSCI World Index return of -8.01 %...Full performance table: Source
km

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Alternative asset firm YieldStreet surpasses $100m of loans funded in less than 8 quarters[more]

    Komfie Manalo, Opalesque Asia: Alternative asset investment platform YieldStreet reported that it has surpassed $100m in loans funded in less than eight quarters from accredited investors and single family offices. YieldStreet was founded by Milind Mehere and Michael Weisz. In a

  2. Investing - Investor appetite for high-growth IPOs to be tested, Apollo boosts fund's stock allowance for 'diamonds in the rough', Hedge funds uncertain over outlook for Hargreaves Lansdown[more]

    Investor appetite for high-growth IPOs to be tested From FT.com: The US listings market is poised for a busy week with deals that will test investors' appetite for high-growth - but lossmaking - companies. Eight new listings are scheduled for this week, the most since October of 2016,

  3. Hedge funds holding Puerto Rico bonds are looking at a long battle[more]

    Komfie Manalo, Opalesque Asia: Hedge funds which bought Puerto Rico's distressed debt bonds are facing the prospect of a long road ahead to recover their investments as the Caribbean island is attempting to use a U.S. Congress-approved rule that allows it to exploit a bankruptcy-like proceedings

  4. Other Voices: "Winner-take-all" dynamics and hedge fund investing[more]

    A growing stream of thinking in microeconomics is the concept of "winner-take-all" dynamics. The idea seems simple. A combination of networking economics and classic economies of scale creates situations where there are just a few dominant firms or economic agents who are able to capture significant

  5. Opalesque Exclusive: WBB enters buy-side with new healthcare long/short strategy[more]

    Benedicte Gravrand, Opalesque Geneva: WBB Securities, a US financial services firm and boutique investment bank since 2001, has a long history within the biotech industry. Managing partner Steve Brozak has been associated with biotech for the last 25-30 years, and was involved with some of the mo